[1]
2023. Alternative Vismodegib Dosing Regimen for Patients with Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 7, 5 (Sep. 2023), 1001–1004. DOI:https://doi.org/10.25251/skin.7.5.5.